Modeling the effects of differential ART scale-up by age and gender in eSwatini Adam Akullian, PhD Postdoctoral Research Scientist | Institute for Disease.

Slides:



Advertisements
Similar presentations
Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
Advertisements

Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
The PEPFAR Blueprint for an AIDS Free Generation Implications for Uganda’s response to HIV Alice Kayongo-Mutebi, Community Health Alliance Uganda 14 February.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Attaining Realistic and Substantial Reductions in HIV Incidence: Model Projections of Combining Microbicide and Male Circumcision interventions in Rural.
HIV Modelling & Economics Estimating the potential impact and efficiency of PrEP for FSWs and MSM in Bangalore, southern India K.M. Mitchell 1, H.J. Prudden.
Accelerating Anti-Retroviral Treatment as a catalytic action for Ending AIDS Pride Chigwedere, MD, PhD Senior Advisor to the African Union AWA CONSULTATIVE.
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
Fast-track to ending AIDS in Zimbabwe: opportunities
What does PrEP mean for people living with HIV? Edwin J Bernard Co-ordinator, HIV Justice Network Consultant, GNP+
What do models estimate to be the impacts on HIV incidence of various percentages of people with HIV on ART ? National AIDS Trust Treatment as Prevention.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
A Method To Help Determine Whether Interventions Have Affected The Natural Course of HIV Epidemics Timothy Hallett & Kelly Sutton Imperial College London.
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Modeling ‘test and treat’ for HIV in South Africa Jan AC Hontelez 1,2,3, Mark N Lurie 4, Till Bärnighausen 3,5, Roel Bakker 1 Rob Baltussen 2, Frank Tanser.
ARV-Based Prevention: Perspective from Epidemiology & Modelling Tim Hallett Imperial College London.
Prevalence and risk factors for self-reported sexually transmitted infections among adults in the Diepsloot informal settlement, Johannesburg, South Africa.
The HIV Care Continuum: A Tool for Driving Systematic Change to Support Better Engagement in Care Jeffrey S. Crowley Distinguished Scholar/ Program Director.
Cost-effectiveness of initiating and monitoring HAART based on WHO versus US DHHS guidelines in the developing world Peter Mazonson, MD, MBA Arthi Vijayaraghavan,
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
Zindoga Mukandavire Social and Mathematical Epidemiology Group London School of Hygiene and Tropical Medicine, UK Improving health worldwide
Boston University Slideshow Title Goes Here District Prevalence of Unsuppressed HIV in South African Women: Monitoring Programme Performance and Progress.
An Historic Opportunity to Prevent the Spread of HIV Timothy Hallett Imperial College London Members of The Applied HIV Epidemiology Research Group / HIV.
Findings from the 2016 Zambia Population-based HIV Impact Assessment (ZAMPHIA): HIV prevalence, incidence and progress towards the goals Danielle.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Peter D Ghys*, Mary Mahy*, Jeff Eaton**, Samir Bhatt**,
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
HIV System Assessment with Longitudinal Treatment Cascade in KwaZulu-Natal, South Africa Noah Haber,1 Frank Tanser,2 Kevindra Naidu,2 Tinofa Mutevedzi,2.
How differentiated care supports “Tx all” and Dr
Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.
HIV and AIDS The management of HIV and AIDS is an ongoing challenge for Anglo companies operating in countries with a high burden of HIV disease Strategy.
Differentiated Service Delivery: Innovating for Impact
Catalina Sol, MPH John Nelson, PhD, CPNP Tisha Wheeler, MSc
Zimbabwe’s shift towards treat all: national country context
Conclusions & Implications
Scale-up of Antiretroviral Therapy and Preexposure Prophylaxis in Swaziland Eugene T. Richardsona, Futhi Dennisb, Nokwazi Mathabelab, Khanya Mabuzab, Allen.
Ambassador Deborah L. Birx, MD
Conclusions Background Results Acknowledgements: Methods
Richard hayes London school of hygiene & Tropical Medicine
Utilizing research as an opportunity to strengthen
Adolescents (10-19 yr) Last updated: October 2017.
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
New Prevention: From DREAMS to Reality
HIV PREVENTION TARGETS FOR ZIMBABWE
Initiatives in HIV.
Tiffany G. Harris, PhD, MS Director of Strategic Information
IAEN Conference (20 July 2018)
Men’s HIV Risk Profiles in South African DREAMS Sites Using latent class analysis for more strategic, context-specific programming and evaluation Ann.
Brief overview of HIV among MSM in the EU/EEA
Reducing risk of male sex partners: HIV testing, treatment, and VMMC of men in PEPFAR-supported DREAMS districts Caroline Cooney1, Kimi Sato2, Shannon.
Evaluating the cost-effectiveness of the test and treat program in Zimbabwe
Global Optimization of the Response to HIV
Heterogeneity of Demographic and Risk Strata Across the UNAIDS Targets in Sub-Saharan Africa – A Systematic Review July 23rd, 2018.
Summary Sheet Figures and Maps
Progress on Voluntary Medical Male Circumcision for HIV prevention and How VMMC fits into UNAIDS ' ' target Julia Samuelson, Nurse epidemiologist.
Trends in the HIV incidence rate following ART scale-up in a rural and hyper-endemic South Africa population (2004–2015) Alain Vandormael, PhD School of.
HIV.
Summary Sheet Figures and Maps
D. T. Hamilton, MPH PhD, S. M. Goodreau, PhD, S. M. Jenness, PhD, P. S
Illustrative Cluster Detection and Response Strategy
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
Start Free, Stay Free, AIDS Free
Update on global progress in ART
University of South Africa
Progress on scaling up HIV prevention
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Modeling the effects of differential ART scale-up by age and gender in eSwatini Adam Akullian, PhD Postdoctoral Research Scientist | Institute for Disease Modeling Affiliate Assistant Professor | Department of Global Health, University of Washington aakullian@idmod.org akullian@uw.edu How many people living with HIV over time? To 2050 and how many are on tx. Number of life years gained over time relative to No ART. Starting in 2020 – 95-95-95 – done in a specific way – use ref tracker to bring youth up to X % Stopping dropout – no drug resistance.

“If you reach 90-90-90, you end up with 73 percent of people with H. I “If you reach 90-90-90, you end up with 73 percent of people with H.I.V. being noncontagious. That 73 percent is the tipping point, at which the epidemic starts to burn out.” Mathematical models have shown that the 90-90-90 goals can theoretically reduce HIV transmission to the point where the epidemic burns out. People waiting to be tested for H.I.V. in Harare, Zimbabwe, in 2012. CreditTsvangirayi Mukwazhi/Associated Press

What do previous models say about the impact of UTT? Hontelez et al., 2013: 90% ART Coverage of 15+ by 2019 results in reduction in incidence to below 1/1000 pyar. Granich et al., 2009: 90% ART coverage by 2016 results in reduction in incidence to below 1/1000 pyar

90-90-90 leaves 27% of HIV positive individuals unsuppressed The impact of 90-90-90 on the HIV epidemic may depend on the risk profile of the missing 27% This is where our work as epidemiologists and mathematical modelers comes in. While the 90-90-90 goals can and should be implemented, we were concerned that they might not be enough to end the epidemic over the next 10-15 years. 90-90-90 leaves 27% of people living with HIV unsuppressed. What if that 27% are disproportionately responsible for transmitting HIV? We published a commentary last month to challenge the scientific community to better understand who those 27% are, and to update our models to better reflect the uncertainty around that group’s contribution to the epidemic.

Goal: Explicitly model the impact of age- and sex- specific differences in ART scale-up towards 90-90-90 in eSwatini

The HIV epidemic in eSwatini PHIA, 2016

Viral load suppression and incidence (2011-2016) HIV incidence (%) PHIA, 2016

Differences in viral load suppression by age and sex PHIA, 2016

Modeling Scenarios ART scale-up to >81% by 2020 and >90% by 2030 with: (a) Maintain current coverage (non age-targeted 90-90-90) (b) Age-targeted campaigns

Scenario a: Maintain current ART coverage

Scenario a: Maintain current ART coverage

Scenario b: Age-targeted scale-up

EMOD Mathematical model calibrated to eSwatini epidemic https://github.com/InstituteForDiseaseModeling/EMOD | www.idmod.org/idmdoc

ART scale-up consistent with incidence declines

Results: incidence reductions by scenario (2016-2050) Men (> 15 years) Women (> 15 years) Age targeting No targeting Additional reduction of 2/1000 infections per year Additional reduction of 3/1000 infections per year

Largest reductions in younger women 5/1000 infections per year 7/1000 infections per year 4/1000 infections per year

Male incidence by age 3/1000 infections per year

Conclusions Recommendations Dramatic ART scale-up in eSwatini  reduced incidence Disparities in ART coverage by age and gender Closing age-gaps in ART coverage can further reduce incidence. Policy: Update 90-90-90 targets to be age and gender-specific Modeling/Data: Improve models to incorporate heterogeneity in ART coverage by demographic / risk indicators Recommendations

Acknowledgements Bill and Melinda Gates Foundation Global Implementing Partners Eswatini MoH Africa Health Research Institute Michelle Morrison Geoff Garnet Emilio Emini Institute for Disease Modelling Anna Bershteyn Britta Jewell Clark Kirkman Dan Bridenbecker

Powers, K. A., et al. (2014). "Impact of early-stage HIV transmission on treatment as prevention." Proc Natl Acad Sci U S A 111(45): 15867-15868.

Model-Based Effects of Universal Test and Treat UTT at 90% ART coverage reduces incidence by 60-80% by 2020 Linear increase in incidence reduction with ART scale-up Percent reduction in incidence Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa. PLoS Medicine 9, e1001245 (2012).

Gender-disparities in transmission driven by age-gaps in partnerships, differential ART coverage, and VMMC Average Time from infection to transmission is short Men (25-34) Women (25-34) aging Women (15-24) Average time from infection to transmission is long de Oliveira, T., et al. Lancet HIV (2017), Akullian et al AIDS (2017)

Model Results: Incidence

Not all age-groups have reached 90-90-90 levels

Modeling the expansion of ART guidelines Eligibility = immediate, CD4 350, CD4 200 Coverage = 50 - 100% 3-year retention = 75 - 100%

Swaziland on track to achieve 90-90-90

Results: Modeled HIV prevalence by age and gender

eSwatini HIV prevalence by age and sex 2016 PHIA, 2016

Viral load suppression by age/sex (KwaZulu-Natal, 2016) Data on who is suppressing are beginning to emerge. The age and sex profile of viral load suppression is now well understood. Women tend to suppress at higher levels than men, especially at younger ages. Part of this is attributed to differences in health seeking behaviors. Women often have more opportunities to access healthcare through ANC visits or are more concerned about their health status. Men tend to delay treatment for a variety of reasons. Data from Grobler et al 2017 “Progression of UNAIDS 90-90-90…” Grobler et al., Progress of UNAIDS 90-90-90 targets in a district in KwaZulu-Natal, South Africa, with high HIV burden, in the HIPSS study: a household-based complex multilevel community survey. The lancet. HIV 4, e505-e513 (2017).

HIV risk depends on partner’s age Women’s report P < 0.01 15,435 pyo 874 seroconverstions Partners < 35 Akullian, A., et al. (2017). "Sexual partnership age-pairings and risk of HIV acquisition in rural South Africa: a population-based cohort study." AIDS (London, England).

EMOD: Model Structure Intrahost Network Interventions Transmission HIV Person STI Person Sexual behavior PreventionProgram HIV Infection infectivity, AIDS prognosis Pair-Forming Algorithm Treatment Program Heterosexual MSM CSW Opportunistic infections Immune State (CD4 etc.) Marital Informal Transitory Transmission Relationship With Interactions Relationship Without Interactions Drug resistance Transmission by Relationship Adherence Profile Transmission by Interaction Single Interaction ARV Regimen

Pair formation algorithm Informal relationship type Age-gaps in sexual partnerships: seeing beyond ‘sugar daddies’, M.Q. Ott, T. Barnighausen, F. Tanser, M.N. Lurie. and M.L. Newell, AIDS, v25, n6, p861, 2011.

Effect of age-targeting: 2016-2030 (age 15-49) No targeting 43% decline 28% decline 48% decline 30% decline 46% decline 29% decline IRD = 0.16/100py IRD = 0.28/100py IRD = 0.22/100py

40-50% decline in incidence between 2010-2016 Ages 15-49